Our in vitro validation showed that Rad51b deletion affects the expression of ERα in mouse Fgfr2-mutant HP5008 cells, Brca1-mutant 545 cells, and the human breast cancer MCF-7 cells. Here, RAD51B is linked to breast carcinoma.